Delivery Order SPE2DB22D1017-SPE2DB25FG9RC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,047.69 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone treatment. The contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, issued on August 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded to the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,461.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone injection medication. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency awarded a delivery order valued at $2,354.52 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- The Defense Logistics Agency awarded a $21,466.53 delivery order to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.10 to AmerisourceBergen Drug Corp for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,917.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a $3,492.30 delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication. This contract is classified as a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and was awarded on August 21, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,774.76 for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. The contract was competitively awarded without set-aside designation on September 5, 2025, with an ultimate completion date of September 8, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.10 to AmerisourceBergen Drug Corp for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed-price, non-set-aside contract was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively small transaction within the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,259.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9RCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,971.47 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. The contract, awarded on August 12, 2025, with completion targeted for August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this order through its Corporate Office division. The place of performance is located in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp was selected competitively for this role as a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/12/25 |